Department of Anus-Intestines, The Eighth People's Hospital of Hefei, Hefei, Anhui Province, China.
Eur Rev Med Pharmacol Sci. 2023 Sep;27(18):8447-8462. doi: 10.26355/eurrev_202309_33768.
The crosstalk between age and immunity in the context of ulcerative colitis (UC) remains incompletely understood. Our objective is to elucidate the specific age-associated genetic factors that modulate immune cell infiltration in UC, with the aim of identifying innovative therapeutic targets for the treatment of this disease.
Potential batch effects between samples were removed by R package "inSilicoMerging". Unsupervised clustering analysis via the "ConsensusClusterPlus" R package was utilized to perform consensus molecular subtyping of immune subtypes in UC. The construction of a heat map was accomplished through the utilization of the R package "pheatmap", while functional enrichment analysis was executed by means of the Metascape database. The identification of the age-related gene module was achieved by performing weighted gene co-expression network analysis (WGCNA) analysis using the R package "WGCNA". The support vector machine (SVM), least absolute shrinkage and selector operation (LASSO), and random forest algorithms were performed via the "e1071", "glmnet" and "randomForest" packages in R, respectively. The diagnostic performance of the parameter was assessed using the receiver operating characteristic (ROC) curve. Correlation analysis was performed by Spearman correlation. The "XSum" package in R was employed to identify potential small-molecule drugs for UC utilizing the Connectivity Map (CMap) database. Molecular docking was performed with Autodock Vina molecular docking software.
A significantly greater frequency of UC patients aged below 40 years was observed in the group with extensive disease extent as compared to those with non-extensive disease extent (70% vs. 47%; Chi-square test, p = 0.02). The application of unsupervised clustering analysis allowed for the stratification of UC patients into two distinct immune subtypes, namely cluster C1 and cluster C2. The distribution of immune subtypes was significantly different between different age categories (Chi-square test, p = 0.00219). The UC samples that were grouped under cluster C1 were distinguished by a higher abundance of macrophages and an elevated number of neutrophils relative to those in cluster C2. Based on both WGCNA and Limma analysis, 146 age-related genes were identified, which exhibited a predominant enrichment in the biological process of cellular senescence. Two age-related genes (MIDN, and PLD6) affecting the immune cell infiltration in UC were identified based on machine learning algorithms (SVM, LASSO, and random forest). The diagnostic performance of MIDN (AUC = 0.93) and PLD6 (AUC = 0.90) in discerning UC patients belonging to cluster C1 was found to be satisfactory, as demonstrated by ROC curve analysis. MIDN demonstrated a positive correlation (r = 0.50, p < 0.0001) with Neutrophil, while PLD6 exhibited a negative correlation (r = -0.52, p < 0.0001) with Neutrophil levels. The "XSum" algorithm revealed that Entinostat has therapeutic potential for UC. The docking glide score between Entinostat and MIDN, and PLD6 protein was -8.9 kcal/mol and -6.8 kcal/mol, respectively.
We have identified two age-related genes, MIDN and PLD6, that are involved in immune cell infiltration in patients with ulcerative colitis. Furthermore, a small molecule drug (Entinostat) with potential therapeutic effects for UC was screened out. This study presented new perspectives on personalized clinical management and therapy research for UC.
溃疡性结肠炎(UC)背景下的年龄与免疫之间的相互作用仍不完全清楚。我们的目的是阐明特定的与年龄相关的遗传因素,这些因素调节 UC 中的免疫细胞浸润,旨在为这种疾病的治疗确定创新的治疗靶点。
通过 R 包“inSilicoMerging”去除潜在的批次效应。通过 R 包“ConsensusClusterPlus”进行无监督聚类分析,对 UC 中的免疫亚型进行共识分子亚型分型。通过使用 R 包“pheatmap”构建热图,通过 Metascape 数据库进行功能富集分析。通过使用 R 包“WGCNA”进行加权基因共表达网络分析(WGCNA)来识别与年龄相关的基因模块。通过 R 中的“e1071”、“glmnet”和“randomForest”包分别执行支持向量机(SVM)、最小绝对收缩和选择器操作(LASSO)和随机森林算法。使用接收器操作特征(ROC)曲线评估参数的诊断性能。通过 Spearman 相关性分析进行相关性分析。使用 R 中的“XSum”包利用 Connectivity Map(CMap)数据库识别潜在的 UC 小分子药物。使用 Autodock Vina 分子对接软件进行分子对接。
在广泛性疾病程度较高的 UC 患者组中,年龄低于 40 岁的患者比例明显高于非广泛性疾病程度的患者组(70%比 47%;卡方检验,p=0.02)。无监督聚类分析可将 UC 患者分为两个不同的免疫亚型,即簇 C1 和簇 C2。免疫亚型的分布在不同年龄组之间存在显著差异(卡方检验,p=0.00219)。与簇 C2 相比,簇 C1 中的 UC 样本中巨噬细胞丰度较高,中性粒细胞数量较多。基于 WGCNA 和 Limma 分析,确定了 146 个与年龄相关的基因,这些基因在细胞衰老的生物学过程中表现出明显的富集。基于机器学习算法(SVM、LASSO 和随机森林),确定了两个影响 UC 免疫细胞浸润的与年龄相关的基因(MIDN 和 PLD6)。MIDN(AUC=0.93)和 PLD6(AUC=0.90)在区分属于簇 C1 的 UC 患者的诊断性能通过 ROC 曲线分析得到了满意的结果。MIDN 与中性粒细胞呈正相关(r=0.50,p<0.0001),而 PLD6 与中性粒细胞呈负相关(r=-0.52,p<0.0001)。“XSum”算法显示 Entinostat 对 UC 具有治疗潜力。Entinostat 与 MIDN 和 PLD6 蛋白之间的对接 glide 评分分别为-8.9 kcal/mol 和-6.8 kcal/mol。
我们确定了两个与年龄相关的基因,MIDN 和 PLD6,它们参与 UC 患者的免疫细胞浸润。此外,筛选出一种具有潜在治疗 UC 作用的小分子药物(Entinostat)。这项研究为 UC 的个性化临床管理和治疗研究提供了新的视角。